Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
WuXi Biologics to Acquire Biologics DS and DP Manufacturing Facilities from Pfizer China
2021-03-17 08:45
WuXi Vaccines Achieves Weather-Tight Construction Milestone on Main Building of Manufacturing Facility Despite COVID-19
2021-03-16 16:30
Remote Pre-Approval Inspection Completed by EMA on WuXi Biologics' MFG4 Facility
2021-03-03 18:23
WuXi Biologics Wins 2021 CMO Leadership Awards in All Six Core Categories
2021-02-25 08:00
The World's Largest 36,000L Biomanufacturing Line Using Single-use Bioreactors Launches GMP Operation at WuXi Biologics
2021-02-09 08:25
WuXi Biologics Receives GMP Certification from Brazil's ANVISA
2020-12-28 17:50
WuXi Biologics to Acquire Drug Substance Facility in Wuppertal, Germany from Bayer
2020-12-21 21:02
Tubulis Forms Strategic Partnership with WuXi Biologics and WuXi STA to Advance New Generation of Antibody-Drug Conjugates towards Clinical Evaluation
2020-12-02 19:00
WuXi Biologics Launched Biologics Integrated Innovation Center in Hangzhou
2020-11-20 16:30
WuXi Biologics and AB2 Bio Announce Collaboration to Accelerate Commercial-Scale Manufacturing of Tadekinig alfa
2020-10-29 17:00
Antengene Announces Collaboration with WuXi Biologics to Advance the Development of Innovative Oncology Medicines
2020-10-15 08:59
WuXi Biologics Records Excellent Interim Results
2020-08-18 00:51
WuXi Vaccines Appoints Mr. Jian Dong as Chief Executive Officer
2020-08-06 17:00
WuXi Biologics Awarded as "Most Honored Company" by Institutional Investor
2020-08-04 17:00
Embrace Change to Turn Challenges into Opportunities: WuXi Biologics Successfully Hosted the 2nd Investor Day
2020-06-19 17:56
WuXi Biologics (Suzhou) Received EMA GMP Certificate for Biosafety Testing
2020-06-16 08:00
WuXi Biologics Signs Lease for a Clinical Manufacturing Facility in the United States
2020-06-09 08:00
WuXi Biologics Sweeps 2020 CMO Leadership Awards in All Six Categories
2020-05-28 08:00
WuXi Biologics Closes Land Deal to Build State-of-the-Art Biologics Production Facility in the United States
2020-05-19 08:00
WuXi Biologics and Aravive Form Strategic Collaboration to Develop Novel High-Affinity Bispecific Antibodies Targeting Cancer and Fibrosis Using the WuXiBody™ Platform
2020-04-30 19:00
1
2
3
4
5
6
9